Embla Medical Valuation Multiples

Embla Medical Overview

About Embla Medical

Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.

Founded

1971

HQ

Employees

4.3K

Website

emblamedical.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $958M

EBITDA: $194M

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Embla Medical Financials

Embla Medical reported last 12-month revenue of $958M and EBITDA of $194M.

In the same LTM period, Embla Medical generated $517M in gross profit, $194M in EBITDA, and $88M in net income.

Embla Medical P&L

In the most recent fiscal year, Embla Medical reported revenue of $929M and EBITDA of $188M.

Embla Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

Embla Medical Stock Performance

Embla Medical has current market cap of $2B, and enterprise value of $2B.

Embla Medical's stock price is $4.57.

Embla Medical Valuation Multiples

Embla Medical trades at 2.5x EV/Revenue multiple, and 12.3x EV/EBITDA.

Embla Medical Financial Valuation Multiples

As of April 19, 2026, Embla Medical has market cap of $2B and EV of $2B.

Equity research analysts estimate Embla Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Embla Medical has a P/E ratio of 22.2x.

Embla Medical Margins & Growth Rates

Embla Medical's revenue in the last 12 month grew by 10%.

Embla Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Embla Medical's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Embla Medical's rule of X is 47% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Embla Medical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Embla Medical M&A Activity

Embla Medical acquired XXX companies to date.

Last acquisition by Embla Medical was on XXXXXXXX, XXXXX. Embla Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Embla Medical Investment Activity

Embla Medical invested in XXX companies to date.

Embla Medical made its latest investment on XXXXXXXX, XXXXX. Embla Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).